Free Trial

Orion Portfolio Solutions LLC Has $5.64 Million Stake in The Allstate Co. (NYSE:ALL)

Allstate logo with Finance background

Orion Portfolio Solutions LLC decreased its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 11.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 29,270 shares of the insurance provider's stock after selling 3,645 shares during the quarter. Orion Portfolio Solutions LLC's holdings in Allstate were worth $5,643,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ALL. United Bank acquired a new stake in Allstate in the third quarter worth about $209,000. FMR LLC grew its position in shares of Allstate by 11.8% during the 3rd quarter. FMR LLC now owns 933,352 shares of the insurance provider's stock worth $177,010,000 after buying an additional 98,179 shares during the period. Townsquare Capital LLC lifted its holdings in Allstate by 9.6% in the third quarter. Townsquare Capital LLC now owns 4,123 shares of the insurance provider's stock valued at $782,000 after buying an additional 360 shares during the period. CreativeOne Wealth LLC lifted its holdings in Allstate by 10.9% in the third quarter. CreativeOne Wealth LLC now owns 6,286 shares of the insurance provider's stock valued at $1,192,000 after buying an additional 620 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Allstate by 8.4% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 119,760 shares of the insurance provider's stock valued at $22,712,000 after acquiring an additional 9,262 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ALL. Wells Fargo & Company increased their price target on Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a research note on Tuesday, January 14th. Argus raised Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. Evercore ISI upgraded Allstate from an "in-line" rating to an "outperform" rating in a research report on Wednesday, January 8th. Barclays cut their price target on shares of Allstate from $187.00 to $183.00 and set an "underweight" rating on the stock in a research report on Monday, January 6th. Finally, Keefe, Bruyette & Woods boosted their price objective on shares of Allstate from $235.00 to $240.00 and gave the company an "outperform" rating in a report on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $219.80.

Get Our Latest Research Report on ALL

Insider Transactions at Allstate

In related news, CFO Jesse E. Merten sold 40,102 shares of the business's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.80% of the company's stock.

Allstate Stock Performance

Shares of NYSE ALL traded down $0.99 during midday trading on Thursday, hitting $204.44. 454,274 shares of the company's stock were exchanged, compared to its average volume of 1,905,576. The firm has a market capitalization of $54.18 billion, a PE ratio of 12.03, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The company's 50 day moving average price is $196.94 and its 200 day moving average price is $194.28. The Allstate Co. has a 12 month low of $156.66 and a 12 month high of $212.91.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. As a group, analysts predict that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.

Allstate Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were given a dividend of $1.00 per share. This is a boost from Allstate's previous quarterly dividend of $0.92. The ex-dividend date was Monday, March 10th. This represents a $4.00 annualized dividend and a yield of 1.96%. Allstate's dividend payout ratio (DPR) is presently 23.54%.

Allstate announced that its board has authorized a share repurchase plan on Wednesday, February 26th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the insurance provider to repurchase up to 3% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board believes its stock is undervalued.

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Further Reading

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines